Prostate Cancer Stereotactic Radiotherapy

NACompletedINTERVENTIONAL
Enrollment

80

Participants

Timeline

Start Date

May 31, 2014

Primary Completion Date

October 31, 2020

Study Completion Date

October 31, 2020

Conditions
Prostate NeoplasmsToxicity Due to Radiotherapy
Interventions
RADIATION

Fractionation

During a radiotherapy period the prostate movement will be monitored by temporary implanted electromagnetic detector. Rectum fixation at 15/39 fractions. DW-MRI at baseline, 3 months and 12 months.

RADIATION

hypofractionated

During a radiotherapy period the prostate movement will be monitored by temporary implanted electromagnetic detector. Rectum fixation at 10/20 fractions. DW-MRI at baseline, 3 months and 12 months

RADIATION

stereotactic fractionation

During a radiotherapy period the prostate movement will be monitored by temporary implanted electromagnetic detector. Rectum fixation at 5/5 fractions. DW-MRI at baseline, 3 months and 12 months

Trial Locations (1)

33521

Tampere University Hospital, Tampere

All Listed Sponsors
lead

Tampere University Hospital

OTHER

NCT02319239 - Prostate Cancer Stereotactic Radiotherapy | Biotech Hunter | Biotech Hunter